About this trial
SBRT uses special equipment to accurately deliver a high dose of radiotherapy to the prostate in a smaller number of treatments. This study is being conducted to find out, for patients with localised intermediate/high risk prostate cancer, whether radiotherapy is best given over 4 weeks (standard image-guided intensity modulated radiotherapy IMRT) or over 1-2 weeks using SBRT.
For patients with localised intermediate/high risk prostate cancer
Where’s this trial being run?
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.Print this page
For more detailed informationClick Here
The PACE Trial (Prostate Advances in Comparative Evidence) International randomised study of prostatectomy vs stereotactic body radiotherapy (SBRT) and conventional radiotherapy vs SBRT for organ-confined prostate cancer.
|Principal Investigator:||Prof. John Armstrong / Dr Alina Mihai|
Cancer Trials Ireland
Ireland: February 2021
|Global Recruitment Target:||1182|
|Ireland Recruitment Target:|